David Lang, M.D.
| Appointed: |
2002 |
| Gender: |
Male |
| Languages: |
English |
Pulmonary, Allergy and Critical Care Medicine
Section Head, Allergy/Immunology
Co-Director, Asthma Center
Biographical Sketch
David M. Lang, MD, is Head of the Section of Allergy/Immunology, Respiratory Institute, Co-Director of the Asthma Center and Director of the Allergy/Immunology Fellowship Training Program at Cleveland Clinic.
He is board-certified by the American Board of Allergy and Immunology, the American Board of Internal Medicine, and the National Board of Medical Examiners.
Previously, he was Section Chief of Allergy/Immunology in the Department of Medicine at Thomas Jefferson University in Philadelphia, Pa., Division Chief of Allergy/Immunology and Co-Director of the Allergy and Asthma Center at Hahnemann University.
Dr. Lang has carried out a number of research projects. He has directed studies of the epidemiology of urban asthma. These studies revealed that in Philadelphia, an alarming rise in annual rates of asthma mortality had occurred--disproportionately affecting African Americans, Hispanic Americans, and residents of poverty areas--and highlighted a dramatic underuse of inhaled steroid medications. He is continuing studies of asthma epidemiology in Ohio.
He was principle investigator of a project investigating risk factors for anaphylactoid reaction to contrast media. This study showed that asthma, cardiovascular disease and beta blocker use were statistically significant risk factors for moderate-to-severe anaphylactoid reaction from intravenous contrast infusion. Females were also found to be at significantly elevated risk for anaphylactoid and severe anaphylactoid reaction from contrast material.
Dr. Lang has been active in national and regional medical organizations, and he has published numerous articles, chapters, and abstracts. Dr. Lang’s professional affiliations include fellowships in the American Academy of Allergy, Asthma, and Immunology; the American College of Allergy, Asthma, and Immunology; and the American College of Physicians. He has also served as president of the Pennsylvania Allergy and Asthma Association.
He is a member of the Joint Council of Allergy, Asthma, and Immunology’s Practice Parameters Task Force, and he contributes as a Sentinel Reader for the online journal Evidence-Based Medicine. He is the current Chair of the American Academy of Allergy, Asthma, and Immunology Health Care, Education, Delivery, and Quality Interest Section.
He was selected as a “Top Doc” in Allergy/Immunology by Cleveland Magazine in 2006, 2007, and 2008, and as one of the Best Doctors in America for 2005-2006 and 2007-2008. He has served as Associate Editor of the Annals of Allergy, Asthma, and Immunology, was the recipient of the Pharmacia Allergy Research Foundation Award at the International College of Allergology and Clinical Immunology in Stockholm in 1994, received the Hahnemann University Hospital Leadership Award in 1996 and the Pennsylvania Allergy and Asthma Association Leadership Award, June, 2002.
Dr. Lang received his medical degree from the University of Michigan in Ann Arbor and completed residency training in Internal Medicine at Henry Ford Hospital in Detroit. Dr. Lang also served an additional year as chief medical resident prior to pursuing subspecialty training in allergy and clinical immunology at Scripps Clinic and Research Foundation in La Jolla, Calif.
Education & Fellowships
| Medical School: | University of Michigan Medical School, Ann Arbor, MI |
|
| Internship: | Henry Ford Hospital, Flexible, Detroit, MI |
| Residency: | Henry Ford Hospital, Internal Medicine, Detroit, MI |
| Fellowship: | Scripps Clinic and Research Foundation, Allergy & Immunology, La Jolla, CA |
| Other Education: | (Undergraduate) University of Michigan, Ann Arbor, MI |
| Other Education: | (Undergraduate) Oakland University, Rochester, MI |
Certifications
Allergy & Immunology
Internal Medicine
Specialty Interests
Asthma, allergic disorders, anaphylaxis, latex allergy, aspirin sensitivity, clinical immunology.
Awards & Honors
Best Doctors 2006-2007, 2008-2009
Professional Memberships
- AAAAI
- ACAAI
- JCAAI
- CAS
- AMA
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/29/2008, Dr. Lang has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Lang receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- AstraZeneca Pharmaceuticals LP
- GlaxoSmithKline
Fiduciary Role. Dr. Lang serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:
- American Academy of Allergy, Asthma, and Immunology
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
